Vickie brings more than 25 years’ relevant health technology industry expertise and a deep commercial capability to successfully bring new interventional cardiac devices to market.
Hydrix Medical is proud to be sponsoring Singapore LIVE 2021, a conference dedicated to cardiovascular intervention in the Asia-Pacific region
First in human clinical trial of the Phyzhon PHYRARI FFR-Wire System will involve approximately 50 patients, commencing in March Quarter 2021
Hydrix is proud to have collaborated with ANSTO on the development of a breakthrough Gamma radiation detection system, the CORIS360™
Hydrix Medical to distribute Phyzhon Health’s disposable fibre optic pressure sensor guidewire used for interventional cardiology procedures
Australian Stock Exchange (ASX) announcement on first US implants of the next-generation AngelMed Guardian® device
Hydrix receives two prestigious Good Design Awards for its outstanding design and engineering work on the Memphasys Felix, a novel IVF technology
AngelMed Guardian implant procedures have been successfully completed in 4 Singaporean patients. Alarms are now programmed and turned on
Australian Stock Exchange (ASX) announcement on implants of AngelMed Guardian devices undertaken in Singapore recently
This webinar provides medical device innovators with an increased understanding of the manufacturing regulatory process.
The Hydrix team is looking forward to collaborating with Venstra Medical to help them develop their ground-breaking technology
The implanted AngelMed Guardian device alerts patients to seek medical attention even if they have no apparent symptoms